Croda International Plc (LON:CRDA - Get Free Report)'s share price reached a new 52-week low during trading on Friday . The stock traded as low as GBX 3,074.50 ($37.99) and last traded at GBX 3,076.01 ($38.01), with a volume of 1058244 shares. The stock had previously closed at GBX 3,111 ($38.45).
Croda International Stock Performance
The stock has a market capitalization of £4.26 billion, a price-to-earnings ratio of 2,606.84, a price-to-earnings-growth ratio of 1.40 and a beta of 0.74. The firm has a fifty day moving average of GBX 3,322.24 and a 200 day moving average of GBX 3,687.45. The company has a debt-to-equity ratio of 30.70, a current ratio of 2.72 and a quick ratio of 2.25.
Insider Buying and Selling at Croda International
In related news, insider Ian Bull acquired 600 shares of the stock in a transaction on Wednesday, November 20th. The shares were bought at an average price of GBX 3,495 ($43.19) per share, with a total value of £20,970 ($25,914.48). Also, insider Danuta Gray acquired 575 shares of the stock in a transaction on Tuesday, December 10th. The shares were bought at an average cost of GBX 3,486 ($43.08) per share, for a total transaction of £20,044.50 ($24,770.76). Over the last three months, insiders have acquired 1,185 shares of company stock valued at $4,133,280. Company insiders own 0.93% of the company's stock.
About Croda International
(
Get Free Report)
Founded in 1925 with the aim of turning bio-based raw materials into innovative ingredients, Croda International is a speciality chemicals company focused on consumer care and life sciences markets. The company is focused on creating, making and selling innovative ingredients that deliver real benefits to a diverse range of customers and employs more than 6,000 people around the world.
Featured Articles
Before you consider Croda International, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Croda International wasn't on the list.
While Croda International currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
